top
Search terms
Results 1 - 7 of 7 - ordered by :
Escardio

The world's greatest event in cardiology, ESC Congress 2013, will take place in Amsterdam, the Netherlands, from 31 August to 4 September, and as ever promises journalists a rich source of front-page ...

Date : 29/07/2013
Escardio

At least 50% of the population is below the age of 25 and the high prevalence of risk factors signals a massive wave of cardiovascular disease in 10-15 years. The cardiac problem is progressing too ...

Date : 13/02/2013
Escardio

Hot Line III - Diabetes Mellitus/Pharmacology In older patients with arthritis and no history of cardiovascular disease, chronic use of any non-steroidal anti-inflammatory drug appears safe from a ...

Date : 31/08/2015
Escardio

An Italian study of men with erectile dysfunction and coronary artery disease (CAD) has shown for the first time that the rates of dysfunction differ according to the type and severity of the ...

Date : 19/07/2006
Escardio

Findings from the Sleep Apnea Cardiovascular Endpoints (SAVE) study were presented at ESC Congress 2016, with simultaneous publication in the New England Journal of Medicine. “Given the level ...

Date : 28/08/2016
Escardio

Hot Line III - Diabetes Mellitus/Pharmacology In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of ...

Date : 31/08/2015
Escardio

ESC’s educational programme² at the congress is a dedicated event that provides an overview of its recent meetings and an insight into new and updated ESC Clinical Practice ...

Date : 12/10/2011